Journal of HIV clinical trials

Marc H.V. Van Regenmortel
Director
CNRS, School of Biotechnology
University of Strasbourg
France Impact Factor: 3.756*
Index Copernicus Value: 5.58

Acquired Immune Deficiency Syndrome (AIDS) is a disease caused due to HIV virus that affects the human immune system. AIDS is the sixth leading cause of death among young adults. Clinical research is a branch of medical science that determines the safety and effectiveness of medications, devices, diagnostic products and treatment regimens intended for human use.

flyer image

The Journal of AIDS & Clinical Research (JAR) is an Open Access Scientific Journal that aims to keep scientists, clinicians, researchers, students, and general public aware of AIDS-related information with a strong focus on basic, clinical and translational science as well as on epidemiology and disease prevention. The journal brings current research from clinical trials and epidemiological reports from around the world. Co-edited by recognized leaders in clinical virology, molecular biology and epidemiology, JAR publishes essential information on advances in the diagnosis and treatment of HIV infections as well as on the development of therapeutics and experimental vaccines. The journal provides a clinically oriented forum for Investigating and treating all sexually transmissible infections, with a special emphasis on HIV.

JAR is a scholarly journal maintains high standards of scientific excellence and its editorial board, which comprises many NIH-supported researchers, ensures a rapid reviewing process with the help of the Editorial Manager System. Manuscripts are accepted for publication only if at least two reviewers agree on the scientific quality of a submitted manuscript.

Journal of AIDS & Clinical Research is associated with “2nd International Conference on HIV/AIDS, STDs, & STIs" (STD-AIDS 2014) during October 27-29, 2014 Las Vegas, USA with a theme “Raising Global Awareness on STD/AIDS and Fighting the Stigma Surrounding the Disease”. The major sessions include Primary HIV Infection, Transmission and Eradication Issues, HIV Diagnosis and Therapy, Social Strategies for HIV and STDs Prevention, HIV Drug Discovery and Research, HIV Related Infections, Co-infections and many more.

*Unofficial 2013 Impact Factor was established by dividing the number of articles published in 2011 and 2012 with the number of times they are cited in 2013 based on Google search and the Scholar Citation Index database. If ‘X’ is the total number of articles published in 2011 and 2012, and ‘Y’ is the number of times these articles were cited in indexed journals during 2013 than, impact factor = Y/X

LAP LAMBERT Academic Publishing The Patients Voice in HIV/AIDS Clinical Trial Participation: What motivates the willingness of HIV infected people to take part in HIV/AIDS clinical trials?
Book (LAP LAMBERT Academic Publishing)
  • Used Book in Good Condition

Call to step up the pace of TB-HIV collaborative activities  — Weekly Blitz
Discovery by biomedical research of new and improved interventions can get into the bucket of implementation.

Related Posts